Clinical trial NCT01295463: Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
Official title: Descriptive Study to Evaluate the Information and Psychosocial Issues on the Risk on Infertility in Cancer Patients After Receiving Treatment in a Comprehensive Cancer Center
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Cancer
Keywords: sexual dysfunction
psychosocial effects of cancer and its treatment
infertility
colon cancer
male breast cancer
breast cancer
germ cell tumor
ovarian sarcoma
uterine sarcoma
chronic lymphocytic leukemia
osteosarcoma
chronic myelogenous leukemia
non-Hodgkin lymphoma
adult acute myeloid leukemia with 11q23 (MLL) abnormalities
adult acute myeloid leukemia with inv(16)(p13;q22)
adult acute myeloid leukemia with t(15;17)(q22;q12)
adult acute myeloid leukemia with t(16;16)(p13;q22)
adult acute myeloid leukemia with t(8;21)(q22;q22)
mast cell leukemia
hairy cell leukemia
prolymphocytic leukemia
adult acute lymphoblastic leukemia
adult acute myeloid leukemia
adult Hodgkin lymphoma
adult T-cell leukemia/lymphoma
small intestine lymphoma
anaplastic large cell lymphoma
angioimmunoblastic T-cell lymphoma
mycosis fungoides/Sezary syndrome
intraocular lymphoma
primary central nervous system non-Hodgkin lymphoma
primary central nervous system Hodgkin lymphoma
noncutaneous extranodal lymphoma
secondary acute myeloid leukemia
acute undifferentiated leukemia
central nervous system leukemia
T-cell large granular lymphocyte leukemia
atypical chronic myeloid leukemia, BCR-ABL1 negative
clear cell sarcoma of the kidney
Kaposi sarcoma
adult soft tissue sarcoma
chronic myelomonocytic leukemia
secondary central nervous system Hodgkin lymphoma
cutaneous lymphoma
adult non-Hodgkin lymphoma
Lead sponsor: National Cancer Institute (NCI)
Sponsor class: NIH
First posted: 2011-02-14
Enrollment: 96
Sex: ALL
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: no

Brief summary: RATIONALE: Learning about the amount of information on fertility and infertility by patients before they received treatment for cancer in a comprehensive cancer center may help doctors plan the best treatment.

PURPOSE: This clinical trial is studying the amount of information on fertility and infertility received by patients before treatment of cancer in patients who have finished treatment.

Detailed description: OBJECTIVES:

Primary

* To determine the amount of information received on aspects of fertility and infertility in patients with cancer prior to receiving treatment in a comprehensive cancer center.

Secondary

* To analyze whether the information received by patients is related to the desire to be parents.
* To analyze whether the information received by patients is related to the desire to be informed.
* To determine whether there is a relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received by patients.

OUTLINE: Patients complete questionnaires (Lickert and QLQ-C30) on the amount of information received prior to therapy and psychosocial issues on aspects of fertility and infertility once within 1-2 years after receiving treatment.

Eligibility criteria: DISEASE CHARACTERISTICS:

* Diagnosis of breast cancer, germ cell tumor, colon cancer, leukemia, lymphoma, or sarcoma

  * Free of disease
* Completed treatment within the past 1-2 years

PATIENT CHARACTERISTICS:

* ECOG performance status 0-1
* Must be able to read and self-complete study questionnaires
* No psychological conditions that may prevent participation in the study

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics
* No concurrent treatment (hormonal treatment for breast cancer is allowed)

Primary outcomes:
measure: Amount of information received on aspects of fertility and infertility
measure: Relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received
Secondary outcomes:
Other outcomes:
Locations:
city: l'Hospitalet de Llobregat
country: Spain
facility: Institut Catala D'Oncologia
Study officials:
affiliation: Institut Català d'Oncologia
name: Josefina Rivera, RGN, MSN
role: PRINCIPAL_INVESTIGATOR
References: